An age curve can look like a story about one life. Often it is a picture assembled from many people of different ages. That distinction matters when a new global study maps where pain is reported, and when.
- The headline total is not the denominator for every pain site.
- A curve through different age groups is not automatically within-person change.
- Use a reference as a comparison question, not a label for what pain someone should accept.
- Publication
- Nature Medicine · 5 October 2026
- Dataset
- 6,125,459 participants; 118 countries and territories
- Measurement
- Population pain reports; mostly cross-sectional data
Original publication: 5 Oct 2026 · The date above refers to this brief.
What the new reference contains
Fillingim and colleagues pooled pain reports from 902 data sources within 138 study programs. They modeled age patterns across 11 anatomical sites, with observations collected during 1990–2025. Coverage and measurement wording varied. Most datasets were cross-sectional. The curves are standardized estimates; they are not records of the same people followed across a century.
Source 1 ↗Why the denominator changes with the question
A participant can contribute to a dataset without contributing to every endpoint in it. Before comparing two pain sites, ask whether both questions were asked in the same samples, with the same time window and the same definition of a positive report.
This is a practical way to read any large pooled resource: place the denominator beside the outcome instead of attaching the largest available total to every result. A huge headline sample can coexist with a much thinner evidence base for a particular place, age or symptom.
Read the horizontal axis carefully
Suppose a survey finds more pain among older respondents than younger respondents. The difference may contain aging, differences between birth cohorts, survival and differences in reporting. Watching the same individuals repeatedly would answer another question.
Our interpretation is that a reference curve is useful for describing where a new sample sits. It becomes misleading when its slope is described as the change an individual will inevitably experience. When reading a lifespan headline, write down whether the observations came from repeated follow-up or different people.
A common symptom is not a standard of acceptable suffering
A reference describes a distribution. It does not establish how much pain is harmless, what caused it or which response is appropriate for a person. A value can be common in a population and still matter greatly to someone experiencing it.
For a research comparison, we would first match age range, symptom definition, recall period and sampling method. Then examine uncertainty and local data coverage. This is our suggested reading sequence, not a clinical decision rule or a tested replacement for assessment.
Connect symptom maps and molecular maps without merging them
The earlier cortex atlas organizes molecular measurements across ages. This pain study organizes population reports. They both offer references, but neither supplies the missing experiment connecting a particular molecular pattern to a particular pain experience.
Our next-study question would be whether a well-defined population comparison remains stable under a different questionnaire and in a new sample. A stronger individual-aging claim would additionally require repeated observations. The opportunity is more comparable measurement; the explanation of every regional difference remains an open research task.
Source 2 ↗Keep the sample, the outcome and the age axis together
Selected publisher methods and limitations checked. These are bibliographic and coverage counts, not a new estimate of pain prevalence. No raw records, workbook or app validation.
01What kind of aging evidence is this?
- What was observed
- Mostly cross-sectional datasets.
- Where the conclusion stops
- Do not treat the curve as a within-person history.
Source 1 · Discussion → limitations
02Are all pain reports measured identically?
- What was observed
- Recall periods and instruments differ.
- Where the conclusion stops
- Standardization does not guarantee identical symptom interpretation across every setting.
Source 1 · Discussion → limitations; Figure 2 caption
Numbers you can inspect
| Measure | Value & unit | Origin & method |
|---|---|---|
| Overall analytic dataset | 6125459 participants | Reported Valid data for at least one pain outcome; not every site. Source 1 · Results → Study population and data coverage |
| Contributing data sources | 902 sources | Reported Includes survey waves and country-specific samples. Source 1 · Methods → Data sources |
| Study programs | 138 programs | Reported A program can supply multiple data sources. Source 1 · Methods → Data sources |
| Geographic coverage | 118 countries and territories | Reported Coverage count, not an equal sample in every country. Source 1 · Results → Study population and data coverage |
Compare the actual experiments
These studies answer different questions. Read the unit and endpoint before comparing results.
| Study | Unit & setting | Readout | Interpretation boundary |
|---|---|---|---|
| Fillingim et al. 2026 Source 1 · Methods → Data sources; Discussion → limitations | Population respondents | Pain reports | An age reference describes populations; it does not determine an individual cause. |
| Yang et al. 2026 Source 2 · Abstract; opening atlas description | Donor tissue and cell nuclei | Cortical RNA patterns | A different biological scale; not a test of the mechanism behind these pain curves. |
The export includes claims, available numbers, methods and source locations. It contains our reading notes and published summaries; it is not raw participant data or an independent reanalysis.
Evidence update · 6 Oct 2026
First publication. Reported values retain their original units and source locations. Proposed next experiments are our interpretation; participant data and source-data files were not reanalysed. AI source check; no human editorial or clinical review.
Three different meanings of a curve
| Question | What you need | Reading boundary |
|---|---|---|
| Where does a sample sit? | A comparable reference and outcome definition | Describe similarity; do not diagnose |
| How does one person change? | Repeated observations over time | Different-age respondents cannot supply that record |
| Why does a difference exist? | A design addressing alternative explanations | A reference pattern alone does not establish a cause |
Original Press-News reading framework. These rows are questions, not additional analyses of the pooled dataset.
Your questions, answered
Were millions of people followed for their entire lives?
No. The paper’s limitations state that most contributing datasets were cross-sectional. Population age patterns and within-person change are different.
Does the total apply to every pain site?
No. Check the outcome-specific sample. Participation in the pooled dataset does not mean every symptom was measured in every person.
Can the curve tell me why I have pain?
No. A population reference does not identify an individual cause or determine an appropriate treatment.
What should I check before comparing a local survey?
Match the age range, question wording, recall period and sampling method. Then inspect uncertainty and whether the reference has adequate coverage for that comparison.
Limits of this interpretation
- Mostly cross-sectional data: age patterns are not individual trajectories.
- Outcome-specific coverage, recall periods, wording and sampling differ.
- The long observation window combines historical and contemporary data.
- We did not test the authors’ benchmarking app or reanalyse their workbook.
Sources & transparency
- Fillingim, Tanguay-Sabourin, Neuert et al. (2026): Global and regional reference curves for pain across the lifespan
Publisher HTML abstract, Results → Study population and data coverage, Figure 2 caption, Methods → Data sources and Discussion limitations checked. Supplementary workbook, participant data and benchmarking app were not reanalysed or tested. CC BY 4.0. This guide describes reference modeling; no personal risk calculator or diagnostic threshold is supplied. · Accessed 6 Oct 2026
DOI: 10.1038/s41591-026-04696-w - Yang, Clarence, Scott et al. (2026): Lifespan single-cell transcriptomic atlas of the human prefrontal cortex
Primary abstract and opening atlas-design description checked. Used only to contrast molecular age references with population symptom references; no biological explanation for the pain curves is inferred. · Accessed 6 Oct 2026
DOI: 10.1038/s41586-026-10271-7
Prepared and source-checked with AI. Press-news Team is the collective publication byline, not a medical reviewer. No human editorial or clinical review has taken place. This is an educational explanation of research methods and basic research, not an individual diagnosis or treatment recommendation. We did not conduct these experiments or reanalyse participant data. The study findings, our interpretation and suggested follow-up tests are distinguished. Source access is recorded below. Photographs are illustrative.
Source check: AI source check — linked primary passages, endpoint boundaries and printed arithmetic
Clinical review: Not applicable to this educational guide
Suggest a correction